Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_assertion type Assertion NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_head.
- NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_assertion description "[Importantly, it also indicates that it is crucial to evaluate the levels of Apaf-1 and XIAP proteins in patient samples before using Smac peptide therapy in the treatment of human leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_provenance.
- NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_assertion evidence source_evidence_literature NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_provenance.
- NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_assertion SIO_000772 12642862 NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_provenance.
- NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_assertion wasDerivedFrom befree-20140225 NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_provenance.
- NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_assertion wasGeneratedBy ECO_0000203 NP700687.RAQGapyAenc7n0Bk-9haIYU-NvkWlE0mxy7vKuvpsEcVw130_provenance.